http://www.phathompharma.com
Phathom Pharmaceuticals, Inc. Company Intro
A late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from GI diseases related to acid.
Industry
Healthcare
Phathom Pharmaceuticals, Inc. Headquaters
100 Campus Drive
Florham Park,07932
United States
Phathom Pharmaceuticals, Inc. Share price
17 May 2023 13:43 GMT
$12.29
-0.22 (-1.76 %)
Phathom Pharmaceuticals, Inc. Market cap
$541.251 M
WMC RANKING
2023
Phathom Pharmaceuticals, Inc. # 504
BiotechnologyLatest Phathom Pharmaceuticals, Inc. News
28 Nov 2023
2023-11-28 | NDAQ:PHAT | Press Release | Phathom ...
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases.
28 Nov 2023
Phathom Pharmaceuticals (PHAT) Announces Commercial ...
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal...
28 Nov 2023
Form 8-K Phathom Pharmaceuticals, For: Nov 28
PHATHOM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter). Delaware, 001-39094, 82-4151574. (State or other jurisdiction of.
WMC Market Score
WMC Market to Revenue Score
Phathom Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Phathom Pharmaceuticals, Inc. | USD | $0 | $138,874 | $-143,770 | $5,413M | 504 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Phathom Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Phathom Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Phathom Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Phathom Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Phathom Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Phathom Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
